China Alzheimer’s Disease Diagnostics Market 2030 Overview, Global Industry Size, Price, Future Analysis
The China Alzheimer’s disease diagnostics market was valued at USD 287.76 million in 2023 and is projected to reach USD 631.73 million by 2030, expanding at a compound annual growth rate (CAGR) of 12.1% from 2024 to 2030. This strong market growth is being driven by several converging factors that are reshaping the landscape of neurological diagnostics in China. One of the primary growth drivers is the increasing prevalence of Alzheimer’s disease (AD) in China, largely due to the country’s rapidly aging population. As the number of elderly individuals rises, so does the incidence of cognitive disorders, particularly Alzheimer’s disease, which has become a major public health concern. Another key factor supporting market expansion is the growing reliance on biomarkers for early and accurate disease diagnosis. Biomarkers such as amyloid beta and tau proteins are increasingly being used to identify, track, and monitor disease progression, offering clinicians more prec...